Grifols, S.A. Company Profile (NASDAQ:GRFS)

About Grifols, S.A. (NASDAQ:GRFS)

Grifols, S.A. logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:GRFS
  • CUSIP: N/A
  • Web: www.grifols.com
Capitalization:
  • Market Cap: $14.13444 billion
  • Outstanding Shares: 1,339,930,000
Average Prices:
  • 50 Day Moving Avg: $21.15
  • 200 Day Moving Avg: $19.39
  • 52 Week Range: $14.27 - $22.83
P/E:
  • Trailing P/E Ratio: 43.34
  • Foreward P/E Ratio: 15.67
  • P/E Growth: 1.29
Sales & Book Value:
  • Annual Revenue: $4.77 billion
  • Price / Sales: 5.72
  • Book Value: $3.26 per share
  • Price / Book: 6.25
Dividend:
  • Annual Dividend: $0.28
  • Dividend Yield: 1.3%
Profitability:
  • EBIDTA: $1.31 billion
  • Net Margins: 13.36%
  • Return on Equity: 17.87%
  • Return on Assets: 6.52%
Debt:
  • Debt-to-Equity Ratio: 1.26%
  • Current Ratio: 2.91%
  • Quick Ratio: 1.38%
Misc:
  • Average Volume: 667,275 shs.
  • Beta: 0.98
  • Short Ratio: 2.01
 
Frequently Asked Questions for Grifols, S.A. (NASDAQ:GRFS)

What is Grifols, S.A.'s stock symbol?

Grifols, S.A. trades on the NASDAQ under the ticker symbol "GRFS."

How often does Grifols, S.A. pay dividends? What is the dividend yield for Grifols, S.A.?

Grifols, S.A. announced a semiannual dividend on Friday, May 26th. Stockholders of record on Thursday, June 1st will be paid a dividend of $0.122 per share on Thursday, June 8th. This represents a dividend yield of 1.54%. The ex-dividend date is Tuesday, May 30th. View Grifols, S.A.'s Dividend History.

When did Grifols, S.A.'s stock split? How did Grifols, S.A.'s stock split work?

Grifols, S.A. shares split on the morning of Monday, January 4th 2016. The 2-1 split was announced on Thursday, December 3rd 2015. The newly minted shares were distributed to shareholders after the closing bell on Thursday, December 31st 2015. An investor that had 100 shares of Grifols, S.A. stock prior to the split would have 200 shares after the split.

Who are some of Grifols, S.A.'s key competitors?

Who owns Grifols, S.A. stock?

Grifols, S.A.'s stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vaughan Nelson Investment Management L.P. (0.20%), Gladstone Capital Management LLP (0.07%), Aperio Group LLC (0.02%), US Bancorp DE (0.01%), CWM LLC (0.01%) and Bank of Montreal Can (0.01%). View Institutional Ownership Trends for Grifols, S.A..

Who sold Grifols, S.A. stock? Who is selling Grifols, S.A. stock?

Grifols, S.A.'s stock was sold by a variety of institutional investors in the last quarter, including Gladstone Capital Management LLP, US Bancorp DE, Independent Portfolio Consultants Inc., OLD National Bancorp IN and Huntington National Bank. View Insider Buying and Selling for Grifols, S.A..

Who bought Grifols, S.A. stock? Who is buying Grifols, S.A. stock?

Grifols, S.A.'s stock was acquired by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Aperio Group LLC, CWM LLC, BB&T Corp, Atria Investments LLC and Bank of Montreal Can. View Insider Buying and Selling for Grifols, S.A..

How do I buy Grifols, S.A. stock?

Shares of Grifols, S.A. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Grifols, S.A.'s stock price today?

One share of Grifols, S.A. stock can currently be purchased for approximately $20.37.


MarketBeat Community Rating for Grifols, S.A. (NASDAQ GRFS)
Community Ranking:  1.8 out of 5 ()
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  178
MarketBeat's community ratings are surveys of what our community members think about Grifols, S.A. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Grifols, S.A. (NASDAQ:GRFS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: N/A

Analysts' Ratings History for Grifols, S.A. (NASDAQ:GRFS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/4/2017Bank of America CorporationReiterated RatingBuyMediumView Rating Details
6/30/2017Goldman Sachs Group, Inc. (The)DowngradeBuy -> NeutralLowView Rating Details
4/7/2017HSBC Holdings plcDowngradeHold -> ReduceMediumView Rating Details
3/30/2017J P Morgan Chase & CoUpgradeNeutral -> OverweightHighView Rating Details
6/6/2016Morgan StanleyReiterated RatingSellN/AView Rating Details
3/17/2016NomuraInitiated CoverageBuyN/AView Rating Details
2/9/2016Berenberg BankUpgradeHold -> BuyN/AView Rating Details
(Data available from 7/25/2015 forward)

Earnings

Earnings History for Grifols, S.A. (NASDAQ:GRFS)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Grifols, S.A. (NASDAQ:GRFS)
2017 EPS Consensus Estimate: $1.13
2018 EPS Consensus Estimate: $1.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.26$0.26$0.26
Q2 20171$0.28$0.28$0.28
Q3 20171$0.28$0.28$0.28
Q4 20171$0.31$0.31$0.31
Q1 20181$0.29$0.29$0.29
Q2 20181$0.32$0.32$0.32
Q3 20181$0.31$0.31$0.31
Q4 20181$0.34$0.34$0.34
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Grifols, S.A. (NASDAQ:GRFS)
Most Recent Dividend:6/8/2017
Annual Dividend:$0.28
Dividend Yield:1.37%
Payout Ratio:30.77% (Trailing 12 Months of Earnings)
24.14% (Based on This Year's Estimates)
21.54% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Grifols, S.A. (NASDAQ:GRFS)

Dividend History by Quarter for Grifols, S.A. (NASDAQ GRFS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/26/2017semiannual$0.121.54%5/30/20176/1/20176/8/2017
11/22/2016$0.1512/5/201612/7/201612/7/2016
5/31/2016$0.116/2/20166/6/20166/6/2016
12/1/2015$0.3012/10/201512/14/201512/14/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Grifols, S.A. (NASDAQ:GRFS)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Grifols, S.A. (NASDAQ:GRFS)
Latest Headlines for Grifols, S.A. (NASDAQ:GRFS)
Source:
DateHeadline
americanbankingnews.com logoGrifols, S.A. (NASDAQ:GRFS) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - July 19 at 12:16 AM
americanbankingnews.com logoGrifols, S.A. (GRFS) Lowered to Sell at BidaskClub
www.americanbankingnews.com - July 5 at 9:54 PM
americanbankingnews.com logoGrifols, S.A. (GRFS) Cut to Neutral at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - June 30 at 10:56 AM
americanbankingnews.com logoGrifols, S.A. (GRFS) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 24 at 12:50 AM
americanbankingnews.com logoGrifols, S.A. (GRFS) Lifted to "Buy" at BidaskClub
www.americanbankingnews.com - June 23 at 9:00 PM
finance.yahoo.com logoGrifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples
finance.yahoo.com - June 23 at 2:27 AM
nasdaq.com logoInteresting GRFS Put And Call Options For February 2018 - Nasdaq ... - Nasdaq
www.nasdaq.com - June 21 at 7:11 PM
finance.yahoo.com logoWhen 'New' Means A Stock Hasn't Led The Market In A While
finance.yahoo.com - June 21 at 7:11 PM
nasdaq.com logoShould Value Investors Consider Grifols (GRFS) Stock Right Now? - Nasdaq
www.nasdaq.com - June 16 at 6:16 PM
finance.yahoo.com logoShould Value Investors Consider Grifols (GRFS) Stock Right Now?
finance.yahoo.com - June 16 at 6:16 PM
finance.yahoo.com logoGrifols and Beckman Coulter Enter into an Exclusive Distribution Agreement
finance.yahoo.com - June 12 at 6:20 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Downgraded by BidAskClub
www.americanbankingnews.com - June 10 at 8:38 AM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Sees Significant Increase in Short Interest
www.americanbankingnews.com - June 2 at 9:14 AM
finance.yahoo.com logoGrifols SA : GRFS-US: Dividend Analysis : June 01st, 2017 (record date) : By the numbers : May 31, 2017
finance.yahoo.com - May 31 at 5:28 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - May 29 at 10:48 PM
americanbankingnews.com logoGrifols SA, Barcelona Announces Dividend of $0.12 (grfs)
www.americanbankingnews.com - May 29 at 10:30 AM
finance.yahoo.com logoHologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents
finance.yahoo.com - May 10 at 5:39 PM
finance.yahoo.com logoInvestigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US
finance.yahoo.com - May 9 at 12:46 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) to Post Q2 2017 Earnings of $0.28 Per Share, William Blair Forecasts
www.americanbankingnews.com - May 8 at 8:21 AM
americanbankingnews.com logoZacks Investment Research Downgrades Grifols SA, Barcelona (GRFS) to Hold
www.americanbankingnews.com - May 5 at 11:26 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 5 at 11:16 PM
americanbankingnews.com logoQ2 2018 EPS Estimates for Grifols SA, Barcelona Decreased by Analyst (GRFS)
www.americanbankingnews.com - May 5 at 6:08 PM
finance.yahoo.com logoVIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y
finance.yahoo.com - May 4 at 12:03 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Receives News Impact Score of 0.25
www.americanbankingnews.com - May 4 at 1:23 AM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Receives News Impact Score of 0.25
www.americanbankingnews.com - May 4 at 1:23 AM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 3 at 12:28 AM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Receives Daily Media Sentiment Rating of 0.31
www.americanbankingnews.com - April 29 at 12:50 AM
finance.yahoo.com logoGlaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View
finance.yahoo.com - April 27 at 6:08 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Receives News Sentiment Score of 0.29
www.americanbankingnews.com - April 25 at 8:12 PM
finance.yahoo.com logoGrifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility
finance.yahoo.com - April 24 at 5:17 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Earning Somewhat Favorable News Coverage, Study Finds
www.americanbankingnews.com - April 22 at 2:51 PM
finance.yahoo.com logoGENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1%
finance.yahoo.com - April 20 at 11:58 AM
finance.yahoo.com logoNivalis' (NVLS) Shares Down After Merger Deal with Alpine
finance.yahoo.com - April 20 at 11:58 AM
finance.yahoo.com logoCan young blood pump new life into treatments for diseases of aging?
finance.yahoo.com - April 19 at 5:24 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Earning Positive News Coverage, Study Shows
www.americanbankingnews.com - April 18 at 4:44 PM
finance.yahoo.com logoGrifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program
finance.yahoo.com - April 17 at 11:12 AM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Downgraded to "Reduce" at HSBC Holdings plc
www.americanbankingnews.com - April 7 at 7:26 PM
finance.yahoo.com logoGrifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017
finance.yahoo.com - April 7 at 10:07 AM
finance.yahoo.com logoSanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk
finance.yahoo.com - April 7 at 10:07 AM
finance.yahoo.com logoAmgen Files for Xgeva Label Expansion, To Include Myeloma
finance.yahoo.com - April 7 at 10:07 AM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 6 at 5:10 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Earns Buy Rating from Analysts at Bank of America Corp
www.americanbankingnews.com - April 6 at 2:16 PM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Stock Rating Upgraded by JPMorgan Chase & Co.
www.americanbankingnews.com - April 5 at 9:04 AM
americanbankingnews.com logoGrifols SA, Barcelona (GRFS) Lifted to Overweight at JPMorgan Chase & Co.
www.americanbankingnews.com - March 30 at 12:28 PM
finance.yahoo.com logoCatalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%
finance.yahoo.com - March 28 at 11:33 AM
finance.yahoo.com logoIs Grifols a Great Stock for Value Investors?
finance.yahoo.com - March 17 at 5:48 PM
zacks.com logoShould You Get Rid of USANA Health Sciences (USNA) Now?
www.zacks.com - March 6 at 8:58 AM
finance.yahoo.com logoHologic Completes Divestiture of Blood Screening Business
finance.yahoo.com - January 31 at 6:09 PM
finance.yahoo.com logoGrifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million
finance.yahoo.com - January 31 at 6:09 PM
finance.yahoo.com logoGrifols, S.A. upgraded by JP Morgan
finance.yahoo.com - January 3 at 8:04 PM

Social

Chart

Grifols, S.A. (GRFS) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by MarketBeat.com Staff